This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Whiteman, L Y Articles by Marciano-Cabral, F Search for Related Content PubMed PubMed Citation Articles by Whiteman, L Y Articles by Marciano-Cabral, F

 Previous Article  |  Next Article 

Infect Immun. 1989 December; 57(12): 3869-3875

Resistance of highly pathogenic Naegleria fowleri amoebae to complement-mediated lysis.

Department of Microbiology and Immunology, Virginia Commonwealth University, Medical College of Virginia, Richmond, 23298-0678.

ABSTRACT

Weakly pathogenic and nonpathogenic Naegleria spp. are readily lysed by human and guinea pig complement. Highly pathogenic Naegleria fowleri are resistant to complement-mediated lysis. Electrophoretic analysis of normal human serum (NHS) incubated with pathogenic or nonpathogenic Naegleria spp. demonstrates that amoebae activate the complement cascade, resulting in the production of C3 and C5 complement cleavage products. To determine whether surface constituents play a role in resistance to complement lysis, trophozoites of Naegleria spp. were subjected to enzymatic treatments prior to incubation in NHS. Treatment of trophozoites with papain or trypsin for 1 h, but not with neuraminidase, increased susceptibility of highly pathogenic Naegleria fowleri to complement lysis. Treatment of trophozoites with actinomycin D or cycloheximide during incubation with NHS or pretreatment with various protease inhibitors for 4 h did not increase the susceptibility of N. fowleri amoebae to lysis. Neither a repair process involving de novo protein synthesis nor a complement-inactivating protease appears to account for the increased resistance of N. fowleri amoebae to complement-mediated lysis.

This article has been cited by other articles:

• Fritzinger, A. E., Toney, D. M., MacLean, R. C., Marciano-Cabral, F. (2006). Identification of a Naegleria fowleri Membrane Protein Reactive with Anti-Human CD59 Antibody. Infect. Immun. 74: 1189-1195 [Abstract] [Full Text]  
• Rojas-Hernandez, S., Rodriguez-Monroy, M. A., Lopez-Revilla, R., Resendiz-Albor, A. A., Moreno-Fierros, L. (2004). Intranasal Coadministration of the Cry1Ac Protoxin with Amoebal Lysates Increases Protection against Naegleria fowleri Meningoencephalitis. Infect. Immun. 72: 4368-4375 [Abstract] [Full Text]